1,4-Diaminobenzene Sulfate | CAS:16245-77-5

We serve 1,4-Diaminobenzene Sulfate CAS:16245-77-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1,4-Diaminobenzene Sulfate

Chemical Name:1,4-Diaminobenzene Sulfate
CAS.NO:16245-77-5
Synonyms:benzene-1,4-diamine,sulfuric acid
Benzene-1,4-diamine sulfate
1,4-Phenylenediamine Sulfate 
p-Phenylenediamine sulfate
Molecular Formula:C6H10N2O4S
Molecular Weight:206.22000
 
Physical and Chemical Properties:
Boiling point:267.4oC;
Flash point:135.9oC;
 
Specification:
Appearance:White crystalline powder
Purity(HPLC):≥99.0%
Ash:≤0.3%
Moisture:≤0.5%
Fe content:≤20ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Hair dyes intermediate



Contact us for information like 1,4-Diaminobenzene Sulfate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,p-Phenylenediamine sulfate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,benzene-1,4-diamine,sulfuric acid Use and application,benzene-1,4-diamine,sulfuric acid technical grade,usp/ep/jp grade.


Related News: API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine.2-methyl-3-methylsulfanylpyrazine manufacturer A system that allows Chinese citizens to enter South Korea’s Jeju Island without a visa is to be temporarily suspended.Dimethoxymethylphenylsilane supplier The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers.N,N'-Carbonyldiimidazole vendor In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.In an August overhaul to its drug administration law, Beijing said conditional approval could be granted to some still-under-research medicines of “predictable” clinical value for life-threatening diseases for which effective treatment is not immediately available.